NCT05960773
- Conditions
- Adenoma, BRCA1-Associated Protein-1 (BAP1) Mutations, Early-stage BAP1-associated Malignancies, +16 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Explore clinical trials studying Malignant Mesothelioma (MM). Study availability and eligibility vary by location and protocol.
NCT05960773
NCT07282873